Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 60,000 shares at $49.63 ($2.9M) on 2020-11-09, disclosed to the SEC on 2020-11-12.
Open-market sale of $2.9M ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.67 | 17,151 | $835K | 28.3% |
| 2 | $48.67 | 17,151 | $835K | 28.3% |
| 3 | $49.63 | 11,089 | $550K | 18.7% |
| 4 | $49.63 | 11,089 | $550K | 18.7% |
| 5 | $50.92 | 1,760 | $90K | 3.0% |
| 6 | $50.92 | 1,760 |
| $90K |
| 3.0% |
| Total | $49.16 avg | 60,000 | $2.9M | 100% |
| Filing → |
| ADPT | SELL | 2021-10-07 | $324K | — | Filing → |
| ADPT | SELL | 2021-09-09 | $940K | — | Filing → |
| ADPT | SELL | 2021-08-12 | $804K | — | Filing → |